News and Comments

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...


Recent Postings


Archive


Tags

Inovio (INO) Dynavax (DVAX) Ionis (IONS) Rapamune Telaprevir Illumina (ILMN) Array Pharmaceuticals (ARRY) Anacor (ANAC) Editas (EDIT) Micromet (MITI) BIOMARIN (BMRN) AERIE PHARMACEUTICALS Advaxis (ADXS) Amgen (AMGN) Herceptin Abbott Laboratories (ABT) KERYX (KERX) ARCA (ABIO) Velcade (bortezomib) Theravance Bio Pharma (TBPH) SERES THERAPEUTICS (MCRB) ISIS (ISIS) ZALTRAP™ HALOZYME (HALO) Zerenex C4 Therapeutics Biocryst (BCRX) Incyte (INCY) Dendreon (DNDN) Jazz Pharmaceuticals (JAZZ) Genentech AstraZeneca (AZN) Spike Therapeutics (ONCE) Valeant Pharmaceuticals International (VRX) Aimmune Therapeutics (AIMT) Alder Biopharmaceuticals (ALDR) Human Longevity (HLI) SUNESIS PHARMACEUTICALS (SNSS) Sequenom (SQNM) Intermune (ITMN) Alnylam (ALNY) RenenxBio (RGNX) Xoma (XOMA) TOKAI (TKAOI) Cytokinetics (CYTK) Elan (ELN) Biogen Idec (BIIB) OSI (OSIP) galapagos (GLPG) Ziofpharm (ZIOP) ABBVIE (ABBV) CRISPR Therapeutics (CRSP) CompuGen (CGEN) Ridaforolimus Adaptimmune (ADAP) Sanofi (SNA) AGOS (ARGS) ADVENTRIX (ANX) Human Genome Sciences (HGSI) Trastuzumab-DM1 Endometrial Cancer JUNO (JUNO) Sangamo (SGMO) GUARDIAN HEALTH KITE (KITE) Idenix (IDIX) Roche (RHHBY) GlaxoSmithKline (GSK) REGULUS (RGLS) Bellicum (BLCM) Agenus (AGEN) Intrexon (XON) Regeneron (REGN) Sarepta (SRPT) Intercept (ICPT) NOVOCURE (NVCR) Benlysta (belimumab) NANTKWEST (NK) Vertex (VRTX) SYNTA (SNTA) Revlimid (lenolidamide) PTC Therapeutics (PTCT) Gilead (GILD) MODERNA Prolor Biotech (PBTH) ImmunoGen (IMGN) Global Cell Therapeutics (GBT) Theravance (THRX) Roche (ROCHE) Agenus (AGEN Galena (GALE) Auspex (ASPX) VANDA (VNDA) Sanofi-Aventis (SAN) Mirati Therapeutics (MRTX) Exelixis (EXEL) Prosensa (RNA) Merck (MRK) ARGOS (ARGS) Seattle Genetics (SGEN) Anadys (ANDS) Ariad (ARIA) Bristol-Myers Squibb (BMY) Multiple Myeloma Onyx (ONXX) IDERA (IDRA) Pluristem (PSTI) Vitae Pharmaceuticals (VTAE) Tysabri NEKTAR (NKTR)) ACADIA (ACAD) INNOVIVA (INVA) Sanofi (SNY)